다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Preventive nutrition and food science, v.24 no.4, 2019년, pp.492 - 497
Baek, Jong Min (HUONS Research Center, Gyeonggi 15588, Korea) , Kim, Hyun Jun (HUONS Research Center, Gyeonggi 15588, Korea) , Nam, Min Woo (HUONS Research Center, Gyeonggi 15588, Korea) , Park, Hyun Jin (HUONS Research Center, Gyeonggi 15588, Korea) , Yeon, Sung Hum (HUONS Research Center, Gyeonggi 15588, Korea) , Oh, Myeong Hwan (HUONS Research Center, Gyeonggi 15588, Korea) , Yoon, Ji Soo (HUONS Research Center, Gyeonggi 15588, Korea) , Kwon, Hyo Jung (Department of Veterinary Pathology, Chungnam National University, Daejeon 34134, Korea) , Lee, Kyu Pil (Laboratory of Physiology, College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Korea) , Lim, Jong Hwan (HUONS Research Center, Gyeonggi 15588, Korea)
AI-Helper
Benign prostatic hyperplasia (BPH) is an age-related disease characterized by prostatic enlargement and is the most common urologic symptoms in elderly men 60 years of age and older. Previously, we documented that 70% ethanol (EtOH) seed extract of Quisqualis indica (QI) attenuates pathological cond...
Bartsch G Rittmaster RS Klocker H Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia Urologe A 2002 41 412 424 10.1007/s00120-002-0230-2 12426858
Brunet A Berger SL Epigenetics of aging and aging-related disease J Gerontol A Biol Sci Med Sci 2014 69 S17 S20 10.1093/gerona/glu042 24833581
Carson C 3rd Rittmaster R The role of dihydrotestosterone in benign prostatic hyperplasia Urology 2003 61 2 7 10.1016/S0090-4295(03)00045-1 12657354
Chapple CR A comparison of varying alpha-blockers and other pharmacotherapy options for lower urinary tract symptoms Rev Urol 2005 4 S22 S30
Chon JK Borkowski A Partin AW Isaacs JT Jacobs SC Kyprianou N Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia J Urol 1999 161 2002 2008 10.1016/S0022-5347(05)68873-8 10332490
Fernstrom MH Fernstrom JD Rapid measurement of free amino acids in serum and CSF using high-performance liquid chromatography Life Sci 1981 29 2119 2130 10.1016/0024-3205(81)90669-X 7311736
Forray C Bard JA Wetzel JM Chiu G Shapiro E Tang R The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype Mol Pharmacol 1994 45 703 708 8183249
Huri HZ Xin CH Sulaiman CZ Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study PLoS One 2014 9 e86215 10.1371/journal.pone.0086215 24475089
Izumi K Mizokami A Lin WJ Lai KP Chang C Androgen receptor roles in the development of benign prostate hyperplasia Am J Pathol 2013 182 1942 1949 10.1016/j.ajpath.2013.02.028 23570837
Janknegt RA Chapple CR Efficacy and safety of the alpha-1 blocker doxazosin in the treatment of benign prostatic hyperplasia. Analysis of 5 studies. Doxazosin Study Groups Eur Urol 1993 24 319 326 10.1159/000474321 7505224
Kim EH Brockman JA Andriole GL The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia Asian J Urol 2018 5 28 32 10.1016/j.ajur.2017.11.005 29379733
Lepor H Medical treatment of benign prostatic hyperplasia Rev Urol 2011 13 20 33 21826125
Lepor H Pathophysiology of benign prostatic hyperplasia in the aging male population Rev Urol 2005 7 S3 S12
Nicholson TM Moses MA Uchtmann KS Keil KP Bjorling DE Vezina CM Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia J Urol 2015 193 722 729 10.1016/j.juro.2014.08.093 25167991
Patil AA Veeresh B Yadav A Combination of lauric acid and myristic acid prevents benign prostatic hyperplasia (BPH) symptoms in animal model Afr J Pharm Pharmacol 2016 10 101 106
Shabbir M Mumtaz FH Benign prostatic hyperplasia J R Soc Promot Health 2004 124 222 227 10.1177/146642400412400519 15493782
Shelbaia A Elsaied WM Elghamrawy H Abdullah A Salaheldin M Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia Urology 2013 82 130 135 10.1016/j.urology.2013.03.026 23711438
Ub Wijerathne C Park HS Jeong HY Song JW Moon OS Seo YW Quisqualis indica improves benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis Biol Pharm Bull 2017 40 2125 2133 10.1248/bpb.b17-00468 28943529
Woodard TJ Manigault KR McBurrows NN Wray TL Woodard LM Management of benign prostatic hyperplasia in older adults Consult Pharm 2016 31 412 424 10.4140/TCP.n.2016.412 27535076
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.